Simon Royal. NIHR; Rebecca Clarke, Layton Medical Centre; Jonathan Abraham, Healum; Sheena Gomez, GlaxoSmithKline
The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. But tapping into that potential requires companies to understand and to plan for primary care. In this session, we will unpick some of the common challenges faced by companies when initiating research in this setting.